Tarsus Pharmaceuticals Inc

TARSNASDAQ
$90.78
7.589.1%
At close: Sep 4, 5:00 PM EST
$91.18
0.400.44%
After Hours: 7:54 PM EST
M&A: Alkeus Pharmaceuticals, Inc was acquired by Tarsus Pharmaceuticals (TARS) on Friday, September 4, 2026 for $450M paid in cash & stock

Tarsus Pharmaceuticals Ownership & Insider Activity

Tarsus Pharmaceuticals (TARS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.0% of shares outstanding. Institutional investors hold 49.2%. Over the past 90 days, insiders made 5 sales worth $3.3M.

Shares Outstanding

43.631M

Shares Float

42.235M

Insider Shares Owned

1.769M

Insider % Owned

4.0%

Institutional Shares Held

21.611M

Institutional % Held

49.2%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

5

$3.3M total

Net Activity

Net Selling

Net Value (90d)

-$3.3M

Tarsus Pharmaceuticals Insider Transactions (Last 6 Months)

See all insider trades
DateInsiderTitleTypeSharesPriceValue
Sep 2, 2026Bobak AzamianPRESIDENT/CEO AND BOARD CHAIRSELL10.000K$80.06$801K
Sep 1, 2026Yeu Elizabeth LinCHIEF MEDICAL OFFICERSELL11.578K$77.56$898K